Circulating tumor HPV DNA as an alternative method to determine HPV status in oropharyngeal squamous cell carcinoma

•ctHPVDNA can effectively confirm HPV-status.•ctHPVDNA may replace additional biopsies in patients with indeterminate FNA results.•A wider application of ctHPVDNA may allow for improved diagnostics. Human Papilloma Virus (HPV) testing is mandatory for all newly diagnosed oropharyngeal squamous cell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oral oncology 2023-05, Vol.140, p.106361-106361, Article 106361
Hauptverfasser: Lambert, Todd, Tasoulas, Jason, Flores, Melissa, Sheth, Siddharth, Patel, Samip N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 106361
container_issue
container_start_page 106361
container_title Oral oncology
container_volume 140
creator Lambert, Todd
Tasoulas, Jason
Flores, Melissa
Sheth, Siddharth
Patel, Samip N.
description •ctHPVDNA can effectively confirm HPV-status.•ctHPVDNA may replace additional biopsies in patients with indeterminate FNA results.•A wider application of ctHPVDNA may allow for improved diagnostics. Human Papilloma Virus (HPV) testing is mandatory for all newly diagnosed oropharyngeal squamous cell carcinoma (OPSCC) due to its importance for prognostication and aiding in treatment decision making. Fine needle aspiration (FNA) is a widely used and accepted diagnostic tool for OPSCC. Although FNA can accurately determine histological diagnosis, results are often indeterminate or lack insufficient samples for HPV testing. For samples with an indeterminant FNA, we propose an alternate method for determining HPV status using circulating tumor tissue modified HPV DNA (ctHPVDNA). We report three cases that confirmed HPV status using ctHPVDNA following an indeterminate FNA. If validated, this non-invasive assay could prevent the need for repeat FNAs or operative biopsies for the sole purpose of determining HPV status.
doi_str_mv 10.1016/j.oraloncology.2023.106361
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2791369525</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1368837523000568</els_id><sourcerecordid>2791369525</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-f88715899fe41b17a824ac4ccb0a7c6fb5151ecfae56478bcef16c9ca0cd00633</originalsourceid><addsrcrecordid>eNqNkEFv1DAQhS0EoqXwF5DFiUsWO4kdh1u1BYpUAQfgak0mk61Xib21nUr993jZgjhyGmveG8-8j7E3UmykkPrdfhMizMFjmMPuYVOLuimCbrR8ws6l6fpKqL55Wt6NNpVpOnXGXqS0F0IoqcRzdtboXqtW1ucsbV3EdYbs_I7ndQmRX3_7ya--XHJIHDyHOVP0Rb8nvlC-DSPPgY9Uuovz9NudMuQ1ced5iOFwC_HB7whmnu5WWEJRkOaZI0R0Pizwkj2bYE706rFesB8fP3zfXlc3Xz993l7eVNgYkavJmE4q0_cTtXKQHZi6BWwRBwEd6mkoYSThBKR025kBaZIaewSBoyg4mgv29vTvIYa7lVK2i0vHU8BTucrWXV8I9apWxfr-ZMUYUoo02UN0SwlipbBH6HZv_4Vuj9DtCXoZfv24Zx0WGv-O_qFcDFcnA5W0946iTejII40uEmY7Bvc_e34BW5mcPg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2791369525</pqid></control><display><type>article</type><title>Circulating tumor HPV DNA as an alternative method to determine HPV status in oropharyngeal squamous cell carcinoma</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Lambert, Todd ; Tasoulas, Jason ; Flores, Melissa ; Sheth, Siddharth ; Patel, Samip N.</creator><creatorcontrib>Lambert, Todd ; Tasoulas, Jason ; Flores, Melissa ; Sheth, Siddharth ; Patel, Samip N.</creatorcontrib><description>•ctHPVDNA can effectively confirm HPV-status.•ctHPVDNA may replace additional biopsies in patients with indeterminate FNA results.•A wider application of ctHPVDNA may allow for improved diagnostics. Human Papilloma Virus (HPV) testing is mandatory for all newly diagnosed oropharyngeal squamous cell carcinoma (OPSCC) due to its importance for prognostication and aiding in treatment decision making. Fine needle aspiration (FNA) is a widely used and accepted diagnostic tool for OPSCC. Although FNA can accurately determine histological diagnosis, results are often indeterminate or lack insufficient samples for HPV testing. For samples with an indeterminant FNA, we propose an alternate method for determining HPV status using circulating tumor tissue modified HPV DNA (ctHPVDNA). We report three cases that confirmed HPV status using ctHPVDNA following an indeterminate FNA. If validated, this non-invasive assay could prevent the need for repeat FNAs or operative biopsies for the sole purpose of determining HPV status.</description><identifier>ISSN: 1368-8375</identifier><identifier>EISSN: 1879-0593</identifier><identifier>DOI: 10.1016/j.oraloncology.2023.106361</identifier><identifier>PMID: 36965412</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Biopsy, Fine-Needle - methods ; ctHPVDNA ; FNA ; Head and Neck Neoplasms ; HPV ; Humans ; Liquid Biopsy ; NavDx ; Oropharyngeal Neoplasms ; Oropharyngeal squamous cell carcinoma ; Papillomaviridae - genetics ; Papillomavirus Infections - complications ; Papillomavirus Infections - diagnosis ; Squamous Cell Carcinoma of Head and Neck</subject><ispartof>Oral oncology, 2023-05, Vol.140, p.106361-106361, Article 106361</ispartof><rights>2023 Elsevier Ltd</rights><rights>Copyright © 2023 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c380t-f88715899fe41b17a824ac4ccb0a7c6fb5151ecfae56478bcef16c9ca0cd00633</citedby><cites>FETCH-LOGICAL-c380t-f88715899fe41b17a824ac4ccb0a7c6fb5151ecfae56478bcef16c9ca0cd00633</cites><orcidid>0000-0002-1923-2309</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1368837523000568$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36965412$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lambert, Todd</creatorcontrib><creatorcontrib>Tasoulas, Jason</creatorcontrib><creatorcontrib>Flores, Melissa</creatorcontrib><creatorcontrib>Sheth, Siddharth</creatorcontrib><creatorcontrib>Patel, Samip N.</creatorcontrib><title>Circulating tumor HPV DNA as an alternative method to determine HPV status in oropharyngeal squamous cell carcinoma</title><title>Oral oncology</title><addtitle>Oral Oncol</addtitle><description>•ctHPVDNA can effectively confirm HPV-status.•ctHPVDNA may replace additional biopsies in patients with indeterminate FNA results.•A wider application of ctHPVDNA may allow for improved diagnostics. Human Papilloma Virus (HPV) testing is mandatory for all newly diagnosed oropharyngeal squamous cell carcinoma (OPSCC) due to its importance for prognostication and aiding in treatment decision making. Fine needle aspiration (FNA) is a widely used and accepted diagnostic tool for OPSCC. Although FNA can accurately determine histological diagnosis, results are often indeterminate or lack insufficient samples for HPV testing. For samples with an indeterminant FNA, we propose an alternate method for determining HPV status using circulating tumor tissue modified HPV DNA (ctHPVDNA). We report three cases that confirmed HPV status using ctHPVDNA following an indeterminate FNA. If validated, this non-invasive assay could prevent the need for repeat FNAs or operative biopsies for the sole purpose of determining HPV status.</description><subject>Biopsy, Fine-Needle - methods</subject><subject>ctHPVDNA</subject><subject>FNA</subject><subject>Head and Neck Neoplasms</subject><subject>HPV</subject><subject>Humans</subject><subject>Liquid Biopsy</subject><subject>NavDx</subject><subject>Oropharyngeal Neoplasms</subject><subject>Oropharyngeal squamous cell carcinoma</subject><subject>Papillomaviridae - genetics</subject><subject>Papillomavirus Infections - complications</subject><subject>Papillomavirus Infections - diagnosis</subject><subject>Squamous Cell Carcinoma of Head and Neck</subject><issn>1368-8375</issn><issn>1879-0593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEFv1DAQhS0EoqXwF5DFiUsWO4kdh1u1BYpUAQfgak0mk61Xib21nUr993jZgjhyGmveG8-8j7E3UmykkPrdfhMizMFjmMPuYVOLuimCbrR8ws6l6fpKqL55Wt6NNpVpOnXGXqS0F0IoqcRzdtboXqtW1ucsbV3EdYbs_I7ndQmRX3_7ya--XHJIHDyHOVP0Rb8nvlC-DSPPgY9Uuovz9NudMuQ1ced5iOFwC_HB7whmnu5WWEJRkOaZI0R0Pizwkj2bYE706rFesB8fP3zfXlc3Xz993l7eVNgYkavJmE4q0_cTtXKQHZi6BWwRBwEd6mkoYSThBKR025kBaZIaewSBoyg4mgv29vTvIYa7lVK2i0vHU8BTucrWXV8I9apWxfr-ZMUYUoo02UN0SwlipbBH6HZv_4Vuj9DtCXoZfv24Zx0WGv-O_qFcDFcnA5W0946iTejII40uEmY7Bvc_e34BW5mcPg</recordid><startdate>202305</startdate><enddate>202305</enddate><creator>Lambert, Todd</creator><creator>Tasoulas, Jason</creator><creator>Flores, Melissa</creator><creator>Sheth, Siddharth</creator><creator>Patel, Samip N.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1923-2309</orcidid></search><sort><creationdate>202305</creationdate><title>Circulating tumor HPV DNA as an alternative method to determine HPV status in oropharyngeal squamous cell carcinoma</title><author>Lambert, Todd ; Tasoulas, Jason ; Flores, Melissa ; Sheth, Siddharth ; Patel, Samip N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-f88715899fe41b17a824ac4ccb0a7c6fb5151ecfae56478bcef16c9ca0cd00633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biopsy, Fine-Needle - methods</topic><topic>ctHPVDNA</topic><topic>FNA</topic><topic>Head and Neck Neoplasms</topic><topic>HPV</topic><topic>Humans</topic><topic>Liquid Biopsy</topic><topic>NavDx</topic><topic>Oropharyngeal Neoplasms</topic><topic>Oropharyngeal squamous cell carcinoma</topic><topic>Papillomaviridae - genetics</topic><topic>Papillomavirus Infections - complications</topic><topic>Papillomavirus Infections - diagnosis</topic><topic>Squamous Cell Carcinoma of Head and Neck</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lambert, Todd</creatorcontrib><creatorcontrib>Tasoulas, Jason</creatorcontrib><creatorcontrib>Flores, Melissa</creatorcontrib><creatorcontrib>Sheth, Siddharth</creatorcontrib><creatorcontrib>Patel, Samip N.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Oral oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lambert, Todd</au><au>Tasoulas, Jason</au><au>Flores, Melissa</au><au>Sheth, Siddharth</au><au>Patel, Samip N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Circulating tumor HPV DNA as an alternative method to determine HPV status in oropharyngeal squamous cell carcinoma</atitle><jtitle>Oral oncology</jtitle><addtitle>Oral Oncol</addtitle><date>2023-05</date><risdate>2023</risdate><volume>140</volume><spage>106361</spage><epage>106361</epage><pages>106361-106361</pages><artnum>106361</artnum><issn>1368-8375</issn><eissn>1879-0593</eissn><abstract>•ctHPVDNA can effectively confirm HPV-status.•ctHPVDNA may replace additional biopsies in patients with indeterminate FNA results.•A wider application of ctHPVDNA may allow for improved diagnostics. Human Papilloma Virus (HPV) testing is mandatory for all newly diagnosed oropharyngeal squamous cell carcinoma (OPSCC) due to its importance for prognostication and aiding in treatment decision making. Fine needle aspiration (FNA) is a widely used and accepted diagnostic tool for OPSCC. Although FNA can accurately determine histological diagnosis, results are often indeterminate or lack insufficient samples for HPV testing. For samples with an indeterminant FNA, we propose an alternate method for determining HPV status using circulating tumor tissue modified HPV DNA (ctHPVDNA). We report three cases that confirmed HPV status using ctHPVDNA following an indeterminate FNA. If validated, this non-invasive assay could prevent the need for repeat FNAs or operative biopsies for the sole purpose of determining HPV status.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>36965412</pmid><doi>10.1016/j.oraloncology.2023.106361</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-1923-2309</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1368-8375
ispartof Oral oncology, 2023-05, Vol.140, p.106361-106361, Article 106361
issn 1368-8375
1879-0593
language eng
recordid cdi_proquest_miscellaneous_2791369525
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Biopsy, Fine-Needle - methods
ctHPVDNA
FNA
Head and Neck Neoplasms
HPV
Humans
Liquid Biopsy
NavDx
Oropharyngeal Neoplasms
Oropharyngeal squamous cell carcinoma
Papillomaviridae - genetics
Papillomavirus Infections - complications
Papillomavirus Infections - diagnosis
Squamous Cell Carcinoma of Head and Neck
title Circulating tumor HPV DNA as an alternative method to determine HPV status in oropharyngeal squamous cell carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T18%3A55%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Circulating%20tumor%20HPV%20DNA%20as%20an%20alternative%20method%20to%20determine%20HPV%20status%20in%20oropharyngeal%20squamous%20cell%20carcinoma&rft.jtitle=Oral%20oncology&rft.au=Lambert,%20Todd&rft.date=2023-05&rft.volume=140&rft.spage=106361&rft.epage=106361&rft.pages=106361-106361&rft.artnum=106361&rft.issn=1368-8375&rft.eissn=1879-0593&rft_id=info:doi/10.1016/j.oraloncology.2023.106361&rft_dat=%3Cproquest_cross%3E2791369525%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2791369525&rft_id=info:pmid/36965412&rft_els_id=S1368837523000568&rfr_iscdi=true